Session 3: Neuroendocrine Dysfunction in Diabetes Mellitus, Diabetic Peripheral Neuropathy, and Care of the Elderly Patient with Type 2 Diabetes.

Date: 7/30/2010 Check-In
 7:45 am - 8:00 am
Educational Session: 8:00 am - 2:00 pm
Joshua J. Neumiller, PharmD, CDE, CGP, FASCP Assistant Professor Department of Pharmacotherapy College of Pharmacy Washington State University, Live CME Instructor for University Learning Systems
Joshua J. Neumiller, PharmD, CDE, CGP, FASCP Assistant Professor Department of Pharmacotherapy College of Pharmacy Washington State University
  1. Explain neuroendocrine dysfunction and how it contributes to metabolic disturbances in diabetes mellitus;
  2. Discuss the incretin effect and its role as a drug therapy target in the management of diabetes, and compare and contrast the pharmacological actions and side effect profiles of GLP-1 agonists (e.g. exenatide) and DPP-4 inhibitors (e.g. sitagliptin, saxagliptin);
  3. Discuss the role of amylinomimetics (e.g. pramlintide) in the treatment of diabetes;
  4. Discuss diabetic peripheral neuropathy and its management;
  5. Discuss care considerations for the elderly patient with type 2 diabetes mellitus..
[an error occurred while processing this directive]